Researchers Imperial College London have developed an #AI #machinelearning tool that can diagnose #Alzheimers #disease at an early stage from a single MRI #brain scan, with the potential to significantly improve #clinical decision-making. Learn more in @GENBio: rb.gy/qsdwee

Pleased to see further expansion for our portfolio company, Healx as it opens new #labs Chesterford Research Park to accelerate its #AI-powered #drugdiscovery for #rarediseases.

Honoured to make the Business Cloud list of the top UK med tech companies this year. Thanks to those who have helped us on our journey so far CMS Ventures Playfair Ascension Life Fund Meltwind Simon Thorpe Hanadi Jabado Cambridge Judge rb.gy/qlnte2

An interesting read in Technology Networks, discussing a breakthrough study by MD Anderson Cancer Center that discovered an atypical form of #collagen produced by #cancer #cells as an immune defence. The study presents a novel, distinct target for cancer #therapeutics: rb.gy/o0qytx

A report in Science Magazine describes the use of #RNA #baseediting to treat #genetic #deafness. Injection of the base editing complex into the ears of mice was able to restore #hearingloss and prevent hair cell loss for up to three months. More here: rb.gy/wpjnji

Great new additions to the Closed Loop Medicine #team, with David Van Sickle joining as Non-Executive Director, and Simon Ramsden as CFO. The #appointments will serve to strengthen the Board and senior #leadership team to drive Company expansion into the US: rb.gy/mlcvso

Learn more about WiLD Hydrogen, an innovative #startup with a mission to create the first and lowest cost negative emissions #hydrogen in the UK, introducing RiPR #technology for scalable hydrogen production with #carbon capture: rb.gy/umlrfb

Using bit.bio’s opti-ox #technology to create a scalable, consistent supply of porcine #cells, Meatable has unveiled its first cultured meat sausage product. Another exciting example of how we can harness #biology to build a more #sustainable future: rb.gy/kcuivc

Pleased to hear that Monument #Therapeutics has received positive #preclinical data for its proprietary #digital #biomarker and #drug MT1988 to treat cognitive impairment in #schizophrenia. Planning for the first human trials has begun. Learn more: rb.gy/n334xe

Great to see NeoPhore Ltd enter a #research collaboration with Memorial Sloan Kettering Cancer Center to determine the potential of its proprietary MMRi #compounds as novel immuno-#oncology #therapeutics that enhance #tumour immunogenicity and induce tumour immunity: rb.gy/eyazkn

What is the Marburg #virus #disease (MVD)? With the first outbreak of MVD in Ghana recently confirmed, BioTechniques reports on the virus’ #epidemiology as well as the need for effective disease monitoring and early-stage prevention. Learn more: rb.gy/2s0kov

Researchers University of Cincinnati and Case Western Reserve have used an NVG-291-R #peptide to block a major #proteoglycan receptor in #stroke animal models, demonstrating significant behavioural recovery accompanied by axonal sprouting and neuroblast migration. Read more in Genetic Engineering & Biotechnology News: rb.gy/miuyzp

We have been listed as number 29 in @BusinessCloud’s #MedTech 50! Over 120 companies were shortlisted, and following 800 reader votes, judges chose the top 50 UK companies creating #innovative #technologies to diagnose and treat #disease. View the list: rb.gy/x9kkts

An interesting read in Forbes from Healx's Co-Founder and CEO, Tim Guilliams, discussing the untapped potential of #AI to support #DrugDiscovery in areas of high unmet need, such as #RareDisease drug development. More here: rb.gy/hsmrxx

We made the BusinessCloud.co.uk MedTech 50 ranking for 2022 🎉 The list is made up of companies advancing technology to help diagnose and treat conditions. Check out the full list 👇 businesscloud.co.uk/medtech-50-uks…

A recent article in Genetic Engineering & Biotechnology News, speaking to Phico Therapeutics CEO Heather Fairhead, looks at the potential for phage therapy to overcome #antibioticresistance and introduce #genetically #engineered #bacteriophages as an alternative to antibiotic treatment. More: rb.gy/ryeo1e

Don’t miss Eagle Genomics as Microsoft’s first #microbiome-focused showcase partner at #ACHEMA22 in #Germany this week. Together, the companies are helping to drive the #biorevolution by enabling the networking of microbiome #science. Learn more: bit.ly/3T0qEZg

A new study reveals that immune defence #genes in #bacteria and archaea can identify #viral proteins. Understanding these interactions can aid the design of #therapeutic #viruses that target specific, pathogenic bacteria. Read more in The Scientist: bit.ly/3PIbvcn